Smyth M (2011): Cancer immunoediting

(56:43)

Tumour immunology and immunotherapy

(5:3)

New Strategies to Enhance the Immunogenicity of Tumors - Merck \u0026 BioMed X Call for Application

(49:1econd)

Tumor Immunogenicity Biomarkers: the Potential of Immunoscore IC® (CD8/PDL1) in Drug Development

(7:11)

[Olga Zimmermannova] Restoring tumor immunogenicity with dendritic cell reprogramming

(26:44)

Michael Milone - Immunotherapy of Cancer Using Genetically Enhanced T Cells

(54:35)

Dr. Glaspy on Immunogenicity in Ovarian Cancer

(1:22)

Padmini Pillai on Immunogenic Death for Cancer Cells

(2:6)

Novel Approaches to Enhancing GBM Immunogenicity for Immunotherapy -Charles Cobbs, M.D.

(22:21)

Immunoengineering 2 - Targeting Tumor Immunogenicity (ICD Induction)

(34:41)

Dr. Arun on Immunogenicity in Triple-Negative Breast Cancer

(1:47)

Dr. Reardon on the Immunogenicity of Glioblastoma

(2:3)

Immunotherapies for GBM: Tumor Vaccines by Linda Liau, M.D., Ph.D., M.B.A.

(46:39)

Cancer immunoediting: basic mechanisms and therapeutic implications

(38:54)

\

(58:41)

NAS Research Briefings: Robert D. Schreiber - Immunity’s Role in Controlling and Shaping Cancer

(22:15)

How Do Tumor Cells Shape Their Immune Microenviorment

(25:13)

Can We Increase the Immunogenicity in MSS CRC?

(19:29)